Efficacy, Immunogenicity and Safety of Vaccination in Pediatric Patients With Autoimmune Inflammatory Rheumatic Diseases (pedAIIRD): A Systematic Literature Review for the 2021 Update of the EULAR/PRES Recommendations.

Jansen, Marc HRondaan, ChristienLegger, GeertjeMinden, KirstenUziel, YosefToplak, NatašaMaritsi, Despoinavan den Berg, MirjamBerbers, GuyBruijning, PatriciaEgert, YonaNormand, ChristopheBijl, MarcFoster, HelenKone-Paut, IsabelleWouters, CarineRavelli, AngeloElkayam, OriWulffraat, Nicolaas MHeijstek, Marloes W2022-08-012022-08-012022-07-062296-23603587458210.3389/fped.2022.910026http://hdl.handle.net/10029/625968enCopyright © 2022 Jansen, Rondaan, Legger, Minden, Uziel, Toplak, Maritsi, van den Berg, Berbers, Bruijning, Egert, Normand, Bijl, Foster, Kone-Paut, Wouters, Ravelli, Elkayam, Wulffraat and Heijstek.immunosuppressantspediatric immunologypediatric rheumatic diseasesafetyvaccinationvaccination responsesEfficacy, Immunogenicity and Safety of Vaccination in Pediatric Patients With Autoimmune Inflammatory Rheumatic Diseases (pedAIIRD): A Systematic Literature Review for the 2021 Update of the EULAR/PRES Recommendations.ArticleFrontiers in pediatrics 2022;10:910026